Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Change in Accured Expenses came in at $21.1 million in Q1 2026, up 180.14% year-on-year from $7.5 million in Q1 2025, and down 66.47% quarter-over-quarter from $62.9 million in Q4 2025.

Koninklijke Philips (PHG) Change in Accured Expenses (2009 - 2026) Analysis & Trends

Koninklijke Philips' Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $21.1 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 180.14% year-over-year to $21.1 million in Q1 2026; TTM through Mar 2026 was $88.9 million, a 158.61% increase from a year earlier, with the FY2023 full-year figure at -$40.9 million, changed N/A from the prior year.
  • Change in Accured Expenses retreated to $21.1 million in Q1 2026 per PHG's latest filing, from $62.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $62.9 million in Q4 2025 and bottomed at -$124.8 million in Q2 2022.
  • The 5-year median for Change in Accured Expenses is -$26.3 million (2025), against an average of -$27.2 million.
  • Across the five-year window, Change in Accured Expenses sank 327.02% in 2022 and surged 215.34% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$85.7 million in 2022, then soared by 52.29% to -$40.9 million in 2023, then sank by 33.29% to -$54.5 million in 2024, then soared by 215.34% to $62.9 million in 2025, then plunged by 66.47% to $21.1 million in 2026.
  • Per Business Quant, the three latest PHG Change in Accured Expenses figures stand at $21.1 million (Q1 2026), $62.9 million (Q4 2025), and $14.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -654.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -347.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 21.07 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -250.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 74.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.07 Mn
Mar 31, 2026 21.07 Mn
Dec 31, 2025 62.86 Mn
Dec 31, 2025 62.86 Mn
Sep 30, 2025 14.03 Mn
Sep 30, 2025 14.03 Mn
Jun 30, 2025 -9.06 Mn
Jun 30, 2025 -9.06 Mn
Mar 31, 2025 -26.30 Mn
Mar 31, 2025 -26.30 Mn
Dec 31, 2024 -54.50 Mn
Dec 31, 2024 -54.50 Mn
Sep 30, 2024 -46.13 Mn
Sep 30, 2024 -46.13 Mn
Jun 30, 2024 -24.77 Mn
Jun 30, 2024 -24.77 Mn
Mar 31, 2024 -11.95 Mn
Mar 31, 2024 -11.95 Mn
Dec 31, 2023 -40.89 Mn
Dec 31, 2023 -40.89 Mn